Stay updated on Pembrolizumab in MSI Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in MSI Tumors Clinical Trial page.

Latest updates to the Pembrolizumab in MSI Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision tag, Revision: v3.6.6, was added to the study record history. The previous Revision: v3.6.5 entry was removed.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe history now shows the latest revision as v3.6.5, replacing the previous v3.6.4.SummaryDifference0.1%

- Check49 days agoChange DetectedA new revision entry v3.6.4 was added to the study history, replacing the previous revision v3.6.3. This updates the history record without modifying study data or results.SummaryDifference0.1%

- Check70 days agoChange DetectedThe record history gains a new revision entry v3.6.3, and the prior revision v3.6.2 is removed from the visible changes.SummaryDifference0.1%

- Check77 days agoChange DetectedThe history now includes a new revision entry v3.6.2, indicating a subsequent update to the record. The previous revision v3.6.0 is no longer listed in the history.SummaryDifference0.1%

- Check92 days agoChange DetectedThe study record now states 'No longer looking for participants', indicating recruitment is closed for this trial. The revision line shows 'Revision: v3.6.0' replacing the previous 'Revision: v3.5.5', signaling an updated version of the study record.SummaryDifference0.3%

Stay in the know with updates to Pembrolizumab in MSI Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MSI Tumors Clinical Trial page.